Researchers from the University of Texas Austin and the National Microbiology Laboratory in Winnipeg will present results on an inhaled Ebola vaccine

A recent preclinical study on this inhalable vaccine is the only evidence to date that a single dose of non -injectable vaccine could provide a long lasting protection from Ebola. The vaccine protected monkeys for over 150 days in trials.

An inhalable vaccine would be easier to store and transport.

For more information check out http://www.dailymail.co.uk/sciencetech/article-2820758/Researchers-reveal-Ebola-vaccine-INHALE-Tests-protects-monkeys-killer-virus-three-months.html or the AARC website at https://www.aarc.org/headlines/index.cfm#professional